Arrowhead Research | ARWR - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
Incyte USD 1.17B 217.51M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
Ligand Pharmaceuticals USD 48.45M 8.22M 2026-03
Merck USD 10.85B 2.57B 2025-12
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 10.07B 184M 2026-03
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
TG Therapeutics USD 171.41M 16.98M 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xencor USD 21M 22.61M 2025-09